Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice.
The development of gene therapy vectors for treating diseases of the cardiovascular system continues at a steady pace. Moreover, in the field of gene therapy the utility of "disease-specific promoters" has strong appeal. Many therapeutic genes, including transforming growth factor beta 1 o...
Main Authors: | Hongqing Zhu, Maohua Cao, Leonardo Mirandola, Jose A Figueroa, Everardo Cobos, Maurizio Chiriva-Internati, Paul L Hermonat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3988062?pdf=render |
Similar Items
-
A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade
by: Leonardo Mirandola, et al.
Published: (2019-12-01) -
The X gene of adeno-associated virus 2 (AAV2) is involved in viral DNA replication.
by: Maohua Cao, et al.
Published: (2014-01-01) -
Aging, cancer, and cancer vaccines
by: Mazzola Paolo, et al.
Published: (2012-04-01) -
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4
by: Jenkins Marjorie R, et al.
Published: (2011-09-01) -
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.
by: Leonardo Mirandola, et al.
Published: (2011-01-01)